Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Korea FDA Moving To Strengthen Pharmacovigilance - APEC Harmonization Center Asia Regulatory Conference

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Korea FDA said it is planning to introduce a set of pharmacovigilance-related policies including the establishment of a national drug safety management center to collect, assess, evaluate and disseminate drug safety information

Related Content

Voices From Emerging Markets Expected At Next ICH Steering Committee - APEC Harmonization Center Regulatory Conference
Effects Of Korea's New Drug-Pricing System Still Murky
Effects Of Korea's New Drug-Pricing System Still Murky
The REMS Filibuster: FDA Wants Ability To End Post-Approval Talks, Make Final Decision
Korea FDA Unveils Initial Biosimilar Guidance; Final Guidelines To Be Released In July
Korean Drug Makers Caught Between GMPs And FTA To Compete Globally



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts